Maryland State Retirement & Pension System Purchases 320 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Maryland State Retirement & Pension System grew its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,036 shares of the medical research company’s stock after acquiring an additional 320 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Thermo Fisher Scientific were worth $15,943,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of TMO. Private Advisor Group LLC raised its holdings in shares of Thermo Fisher Scientific by 88.0% in the 4th quarter. Private Advisor Group LLC now owns 21,996 shares of the medical research company’s stock valued at $11,676,000 after acquiring an additional 10,295 shares in the last quarter. MeadowBrook Investment Advisors LLC purchased a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at about $1,824,000. Clifford Swan Investment Counsel LLC increased its position in shares of Thermo Fisher Scientific by 2.9% during the 4th quarter. Clifford Swan Investment Counsel LLC now owns 755 shares of the medical research company’s stock valued at $401,000 after purchasing an additional 21 shares during the last quarter. Metis Global Partners LLC increased its position in shares of Thermo Fisher Scientific by 15.6% during the 4th quarter. Metis Global Partners LLC now owns 20,902 shares of the medical research company’s stock valued at $11,095,000 after purchasing an additional 2,828 shares during the last quarter. Finally, Valley Brook Capital Group Inc. grew its position in Thermo Fisher Scientific by 3.3% during the 4th quarter. Valley Brook Capital Group Inc. now owns 4,660 shares of the medical research company’s stock worth $2,473,000 after acquiring an additional 150 shares during the last quarter. Institutional investors own 89.23% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on TMO. Evercore ISI increased their price objective on Thermo Fisher Scientific from $575.00 to $610.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Royal Bank of Canada increased their price objective on Thermo Fisher Scientific from $592.00 to $642.00 and gave the stock an “outperform” rating in a report on Thursday, February 1st. Barclays lifted their price objective on Thermo Fisher Scientific from $590.00 to $615.00 and gave the company an “equal weight” rating in a research note on Thursday, April 25th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Thermo Fisher Scientific in a report on Monday, January 8th. Finally, JPMorgan Chase & Co. boosted their price target on Thermo Fisher Scientific from $600.00 to $650.00 and gave the stock an “overweight” rating in a research note on Thursday, April 25th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $607.35.

Insider Activity

In other news, Director Debora L. Spar sold 164 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $546.97, for a total value of $89,703.08. Following the completion of the sale, the director now owns 1,207 shares in the company, valued at $660,192.79. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 10,000 shares of the firm’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $572.41, for a total value of $5,724,100.00. Following the sale, the chief executive officer now directly owns 123,816 shares in the company, valued at approximately $70,873,516.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Debora L. Spar sold 164 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $546.97, for a total value of $89,703.08. Following the sale, the director now owns 1,207 shares in the company, valued at $660,192.79. The disclosure for this sale can be found here. In the last 90 days, insiders sold 62,277 shares of company stock worth $35,373,364. Insiders own 0.34% of the company’s stock.

Thermo Fisher Scientific Stock Performance

TMO stock traded down $1.32 on Tuesday, reaching $572.23. The company’s stock had a trading volume of 892,208 shares, compared to its average volume of 1,536,950. Thermo Fisher Scientific Inc. has a 52 week low of $415.60 and a 52 week high of $603.82. The company has a market capitalization of $218.43 billion, a P/E ratio of 36.79, a price-to-earnings-growth ratio of 2.37 and a beta of 0.80. The firm has a fifty day moving average of $575.59 and a two-hundred day moving average of $534.36. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.70 and a quick ratio of 1.33.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, April 24th. The medical research company reported $5.11 earnings per share for the quarter, topping analysts’ consensus estimates of $4.70 by $0.41. The firm had revenue of $10.35 billion during the quarter, compared to the consensus estimate of $10.14 billion. Thermo Fisher Scientific had a return on equity of 18.45% and a net margin of 14.20%. As a group, analysts predict that Thermo Fisher Scientific Inc. will post 21.64 EPS for the current fiscal year.

Thermo Fisher Scientific Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Friday, March 15th were given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date of this dividend was Thursday, March 14th. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.35. Thermo Fisher Scientific’s dividend payout ratio is 10.01%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.